In women (with or without SLE) with a high-risk aPL profile and without a personal history of thrombosis or pregnancy complications, EULAR recommends primary prophylaxis with LDA (75–100 mg/day) during pregnancy [29]. Here, FASLG is linked to systemic lupus erythematosus.